Cargando…
Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, is an urgent global health problem requiring new drugs, new drug targets, and an increased understanding of antibiotic resistance. We have determined the mode of resistance to be a series of arylamide compounds in M. tuberculosis. We isolated M. tu...
Autores principales: | Shelton, Catherine D., McNeil, Matthew B., Early, Julie V., Ioerger, Thomas R., Parish, Tanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092897/ https://www.ncbi.nlm.nih.gov/pubmed/33619059 http://dx.doi.org/10.1128/AAC.02334-20 |
Ejemplares similares
-
In Vitro Isolation and Characterization of Oxazolidinone-Resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2017) -
Activation of 2,4-Diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a Putative Dioxygenase
por: Melief, Eduard, et al.
Publicado: (2018) -
Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis
por: Shelton, Catherine, et al.
Publicado: (2022) -
A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis
In Vitro
por: Patel, Nipul, et al.
Publicado: (2017) -
Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels
por: O'Malley, Theresa, et al.
Publicado: (2018)